Skip to content
Screener

Neogen NEOG Total Equity

Total Equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$52.69B+4.3%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$1.61B+10.5%
Zoetis logo
ZoetisZTS
$3.15B-36.7%
Revvity logo
RevvityRVTY
$7.18B-5.9%
Merck & Co. logo
Merck & Co.MRK
$41.93B-14.4%
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2.46B+138%
Enterprise value$3.1B+70.0%
P/S2.8×+1.7×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Neogen’s 10-Q, filed April 9, 2026.

Filed
Apr 9, 2026, 4:03 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-149599
AssetsFebruary 28, 2026 / (unaudited)May 31, 2025
Equity
Preferred stock, $1.00 par value, 100,000 shares authorized, none issued and outstanding
Common stock, $0.16 par value, 315,000,000 shares authorized, 217,673,041 and 217,044,098 shares issued and outstanding34.834.7
Additional paid-in capital2,613.12,601.8
Accumulated other comprehensive loss(12.5)(28.9)
Accumulated deficit(533.0)(536.4)
Total Stockholders’ Equity2,102.42,071.2
Total Liabilities and Stockholders’ Equity$3,359.0$3,443.8

Item 1. Interim Condensed Consolidated Financial Statements

FAQ

What is Neogen's total equity?
Neogen (NEOG) reported total equity of $2.1B in Q4 2025.
How has Neogen's total equity changed year-over-year?
Neogen's total equity decreased by 21.0% year-over-year, from $2.66B to $2.1B.
What is the long-term trend for Neogen's total equity?
Over 4 years (2021 to 2025), Neogen's total equity has grown at a 25.3% compound annual growth rate (CAGR), from $840.38M to $2.07B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Neogen's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude